LIMINATUS PHARMA, INC. (LIMN) Return on equity
LIMINATUS PHARMA, INC. (LIMN) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to LIMNSource: SEC XBRL filings · For reference only · Not investment advice
More LIMN financial trends
LIMN RevenueLIMN Net incomeLIMN Net marginLIMN Gross profitLIMN Gross marginLIMN Operating incomeLIMN Operating marginLIMN Operating cash flowLIMN Free cash flowLIMN Capital expendituresLIMN Stock buybacksLIMN Dividends paidLIMN Total assetsLIMN Total liabilitiesLIMN Shareholders’ equityLIMN overview →